ArticleFrontiers in oncology2023

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy.

Cheng Ming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.